Evaluation of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase9 (MMP9) and their complex MMP9/NGAL in sera and urine of patients with kidney tumors

Author：  

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.5, Iss.5, 2013-01, pp. : 1677-1681

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of MMP2, MMP9, TIMP1, TIMP2, NGAL and MMP9/NGAL complex in urine and sera from patients with bladder cancer

By      

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2527-2532

Spandidos Publications

Access to resources Recommend Favorite

NGAL knockdown by siRNA in human cholangiocarcinoma cells suppressed invasion by reducing NGAL/MMP-9 complex formation

By Nuntagowat Chalinee   Leelawat Kawin   Tohtong Rutaiwan  

Clinical and Experimental Metastasis, Vol. 27, Iss. 5, 2010-05 ,pp. : 295-305

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic significance of urine neutrophil gelatinase-associated lipocalin in patients with septic acute kidney injury

By Guo Yong   Yan Kui-Po  

Experimental and Therapeutic Medicine, Vol. 2, Iss. 6, 2011-11 ,pp. : 1133-1139

Spandidos Publications

Access to resources Recommend Favorite

Matrix metalloproteinase2 and 9 and tissue inhibitor of metalloproteinase1 and 2 in sera and urine of patients with renal carcinoma

By  

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 621-626

Spandidos Publications

Access to resources Recommend Favorite

MMP-9 (Gelatinase B) Expression is Associated With Disease-Free Survival and Disease-Specific Survival in Colorectal Cancer Patients

By Bendardaf Riyad   Buhmeida Abdelbaset   Hilska Marja   Laato Matti   Syrjänen Stina   Syrjänen Kari   Collan Yrjö   Pyrhönen Seppo  

Cancer Investigation, Vol. 28, Iss. 1, 2010-01 ,pp. : 38-43

Informa Healthcare

Access to resources Recommend Favorite